Cyclic, disulfide- and dithioether-containing opioid tetrapeptides: Development of a ligard with high delta opioid receptor selectivity and affinity
dc.contributor.author | Mosberg, Henry I. | en_US |
dc.contributor.author | Omnaas, John R. | en_US |
dc.contributor.author | Medzihradsky, Fedor | en_US |
dc.contributor.author | Smith, Charles B. | en_US |
dc.date.accessioned | 2006-04-07T20:33:49Z | |
dc.date.available | 2006-04-07T20:33:49Z | |
dc.date.issued | 1988 | en_US |
dc.identifier.citation | Mosberg, Henry I., Omnaas, John R., Medzihradsky, Fedor, Smith, Charles B. (1988)."Cyclic, disulfide- and dithioether-containing opioid tetrapeptides: Development of a ligard with high delta opioid receptor selectivity and affinity." Life Sciences 43(12): 1013-1020. <http://hdl.handle.net/2027.42/27602> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6T99-475TF3Y-2W/2/09465cd3ea5608d4f9347b6fdfb2ad22 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/27602 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=2845204&dopt=citation | en_US |
dc.description.abstract | Tetrapeptides of primary sequence Tyr-X-Phe-YNH2, where X is D-Cys or D-Pen (penicillamine) and where Y is D-Pen or L-Pen, were prepared and were cyclized via the side chain sulfurs of residues 2 and 4 to disulfide or dithioether-containing analogs. These peptides are related to previously reported penicillamine-containing pentapeptide enkephalin analogs but lack the central glycine residue of the latter and were designed to assess the effect of decreased ring size on opioid activity. Binding affinities of the tetrapeptides were determined to both [mu] and [delta] opioid receptors. Binding affinity and selectivity in the tetrapeptide series were observed to be highly dependent on primary sequence. For example, L-Pen4 analogs displayed low affinity and were nonselective, while the corresponding D-Pen4 diastereomers were of variable affinity and higher selectivity. Among the latter compounds were examples of potent analogs in which selectivity shifted from [delta] selective to [mu] selective as the ring size was increased. The relatively high binding affinity and [delta] receptor selectivity observed with one of the carboxamide terminal disulfide analogs led to the synthesis of the corresponding carboxylic acid terminal, Tyr-D-Cys-Phe-D-PenOH. This analog displayed [delta] receptor binding selectivity similar to that of the standard [delta] ligand, [D-Pen2, D-Pen5] enkephalin (DPDPE), and was found to have a 3.5-fold higher binding affinity than DPDPE. All the tetrapeptides were further evaluated in the isolated mouse vas deferens (mvd) assay and all displayed opioid agonist activity. In general, tetrapeptide potencies in the mouse vas deferens correlated well with binding affinities but were somewhat lower. Receptor selectivity in the mvd, assessed by examining the effect of opioid antagonists on the tetrapeptide concentration-effect curves, was similar to that determined in the binding studies. | en_US |
dc.format.extent | 488262 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Cyclic, disulfide- and dithioether-containing opioid tetrapeptides: Development of a ligard with high delta opioid receptor selectivity and affinity | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Natural Resources and Environment | en_US |
dc.subject.hlbsecondlevel | Molecular, Cellular and Developmental Biology | en_US |
dc.subject.hlbsecondlevel | Ecology and Evolutionary Biology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Pharmacology (F.M., C.B.S.), The University of Michigan, Ann Arbor, MI 48109, USA; College of Pharmacy (H.I.M., J.R.O.), Department of Biological Chemistry (F.M.), The University of Michigan, Ann Arbor, MI 48109, USA. | en_US |
dc.contributor.affiliationum | Department of Pharmacology (F.M., C.B.S.), The University of Michigan, Ann Arbor, MI 48109, USA; College of Pharmacy (H.I.M., J.R.O.), Department of Biological Chemistry (F.M.), The University of Michigan, Ann Arbor, MI 48109, USA. | en_US |
dc.contributor.affiliationum | Department of Pharmacology (F.M., C.B.S.), The University of Michigan, Ann Arbor, MI 48109, USA; College of Pharmacy (H.I.M., J.R.O.), Department of Biological Chemistry (F.M.), The University of Michigan, Ann Arbor, MI 48109, USA. | en_US |
dc.contributor.affiliationum | Department of Pharmacology (F.M., C.B.S.), The University of Michigan, Ann Arbor, MI 48109, USA; College of Pharmacy (H.I.M., J.R.O.), Department of Biological Chemistry (F.M.), The University of Michigan, Ann Arbor, MI 48109, USA. | en_US |
dc.identifier.pmid | 2845204 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/27602/1/0000646.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0024-3205(88)90547-4 | en_US |
dc.identifier.source | Life Sciences | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.